-
Committed to Cachexia: A Decade of LUNGevity Research
Read time: 4 minutes. LUNGevity Foundation stands at the forefront of lung cancer research and advocacy, driven by a mission to improve outcomes for patients through research -
Sharing Experiences With EGFR Lung Cancer: A Tool Shaped by Patients and Caregivers
Read time: 3 minutes. Why did we build a tool to visualize data collected from patients and caregivers? Community members provide data but too often never see how their data was -
A Future of Unifying Cancer Science and Medicine: Highlights from AACR 2025
Read time: 9 minutes. More than 22,000 cancer researchers from 81 countries got together for the annual American Association for Cancer Research (AACR) meeting in Chicago from -
The Promise of PROTACs for Treating RET+ Lung Cancer
Read time: 3 minutes. RET proteins are a type of receptor tyrosine kinase—an important group of signaling molecules in healthy cells. When RET proteins are turned “on” and “off” in -
Small Cell Lung Cancer: The Dial Is Starting to Move
Read time: 6 minutes. The research community is finally beginning to gain traction and make real progress in treating small cell lung cancer (SCLC). The SCLC Hot Topic Meeting -
Conversations that Count: Patient Engagement Strategies to Advance Outcomes of Patients with Lung Cancer
Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts